Digestion Aids Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2028

The global digestion aids market is anticipated to grow at a significant CAGR during the forecast period. The market growth is largely attributable to the growing prevalence of digestive diseases all over the globe. The underlying cause of such diseases lies in the sedentary lifestyle. This, in turn, is driving the demand for digestion aids products. In various developed economies where growing health awareness has resulted in an elevated per capita expenditure, the adoption of digestive health aids has been observed as a prominent market trend.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/digestion-aids-market

There has been observed an increased consumption of packaged as well as junk food due to the growing working population all over the globe that prefers ready to eat products over opting for homemade meals. This has resulted in elevated consumptions of high-sodium foods which primarily interferes with the body’s digestive mechanism. Thus, the high prevalence of digestive disorders is particularly noted in the economies of the US, Japan, and several European countries, which is further anticipated to propel the digestion aids products demand. The growing number of gastrointestinal disorders, primarily including the constipation, acidity, and diarrhea, has resulted in the growing number of consumers seeking digestion aids on a regular basis.

Some key players operating in the market include Abbott Laboratories, Yakult Honsha Co., Ltd., and Chr. Hansen A/S, among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in July 2017, Alcresta Therapeutics received 510(K) clearance from the US Food and Drug Administration (FDA) for the use of RELiZORB in children. RELiZORB is used for pancreatic and gastric disorders in both children and adults.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered-

o             By Product Type

o             By Formulation

o             By Distribution Channel

  • Regions covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

  • Competitive Landscape:  Abbott Laboratories, Yakult Honsha Co., Ltd., and Chr. Hansen A/S, among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o             Deviation from the pre-COVID-19 forecast

o             Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Digestion Aids Market Report by Segment

By Product Type

  • Prebiotics
  • Probiotics
  • Digestive Enzymes
  • Drugs

By Formulation

  • Tablets
  • Liquids
  • Powder

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce
  • Supermarkets and General Stores

A full report of Digestion Aids Market is available at: https://www.omrglobal.com/industry-reports/digestion-aids-market